Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation.

Publication Year: 2022

DOI:
10.1111/add.16063

PMCID:
PMC10092879

PMID:
36208090

Journal Information

Full Title: Addiction

Abbreviation: Addiction

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Substance-Related Disorders

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1."

Code Sharing
Evidence found in paper:

"DECLARATION OF INTERESTS A.R.B., A.T., J.H.B., N.L., I.O.: none to declare. P.H. provided consultancy to and received research funding from Pfizer. C.B. is an investigator on grants and contracts for research on tobacco control from the Health Research Council of NZ, the NHMRC Australia, NZ Ministry of Health and Auckland Council. He has provided consultancy to J&J Japan on NRT products. N.A.R. has received royalties from UpToDate, Inc., for chapters on electronic cigarettes. Outside the topic of e‐cigarettes, she has consulted for and received a research grant from Achieve Life Sciences."

Evidence found in paper:

"Funding information Cancer Research UK; University of Oxford Policy Challenge Fund; National Institute for Health Research (NIHR)"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025